Beneficial effect of Hydroxychloroquine-Azithromycin combination in the treatment of elderly patients with Covid-19: results of an observational study

{ 'indexed': {'date-parts': [[2022, 6, 21]], 'date-time': '2022-06-21T13:09:06Z', 'timestamp': 1655816946139}, 'reference-count': 11, 'publisher': 'Elsevier BV', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2020, 12, 1]], 'date-time': '2020-12-01T00:00:00Z', 'timestamp': 1606780800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': ['clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 12]]}, 'DOI': '10.1016/j.phclin.2020.06.001', 'type': 'journal-article', 'created': {'date-parts': [[2020, 6, 9]], 'date-time': '2020-06-09T02:53:19Z', 'timestamp': 1591671199000}, 'page': '398-403', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 2, 'title': 'Effet bénéfique de l’association hydroxychloroquine/azithromycine dans le traitement des ' 'patients âgés atteints de la COVID-19\xa0: résultats d’une étude observationnelle', 'prefix': '10.1016', 'volume': '55', 'author': [ {'given': 'G.', 'family': 'Pirnay', 'sequence': 'first', 'affiliation': []}, {'given': 'B.', 'family': 'Dantier', 'sequence': 'additional', 'affiliation': []}, {'given': 'W.', 'family': 'Tourid', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Terkemani', 'sequence': 'additional', 'affiliation': []}, {'given': 'F.', 'family': 'Bachot', 'sequence': 'additional', 'affiliation': []}, {'given': 'L.', 'family': 'Hadim', 'sequence': 'additional', 'affiliation': []}, {'given': 'N.', 'family': 'Abdous', 'sequence': 'additional', 'affiliation': []}, {'given': 'W.', 'family': 'Amara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Z.', 'family': 'Abrous', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Bozel', 'sequence': 'additional', 'affiliation': []}, {'given': 'M.-L.', 'family': 'Gaubert-Dahan', 'sequence': 'additional', 'affiliation': []}, {'given': 'R.', 'family': 'Aikpa', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-0911-5755', 'authenticated-orcid': False, 'given': 'F.', 'family': 'Fauvelle', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.phclin.2020.06.001_bib0060', 'series-title': 'INSEE données statistiques au 7\xa0mai 2020\xa0sur la mortalité en 2020', 'year': '2020'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0065', 'unstructured': 'Décret no\xa02020-314\xa0du 25\xa0mars 2020\xa0complétant le décret ' 'no\xa02020-293\xa0du 23\xa0mars 2020\xa0prescrivant les mesures ' 'générales nécessaires pour faire face à l’épidémie de COVID-19\xa0dans ' 'le cadre de l’état d’urgence sanitaire. [Consulté le 11\xa0mai 2020].'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0070', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycine as a treatment of COVID-19: ' 'results of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0075', 'series-title': 'Early treatment of 1061\xa0COVID-19\xa0patients with hydroxychloroquine ' 'and azithromycin, Marseille, France', 'author': 'Million', 'year': '2020'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0080', 'doi-asserted-by': 'crossref', 'first-page': '105948', 'DOI': '10.1016/j.ijantimicag.2020.105938', 'article-title': 'New insights on the antiviral effects of chloroquine against ' 'coronavirus: what do expect for COVID-19?', 'volume': '55', 'author': 'Devaux', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, {'key': '10.1016/j.phclin.2020.06.001_bib0085', 'series-title': 'ANSM', 'year': '2020'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0090', 'first-page': '7', 'article-title': 'XVe\xa0Conférence de consensus en thérapeutique anti-infectieuse\xa0: ' 'prise en charge des infections des voies respiratoires basses de ' 'l’adulte immunocompétent', 'volume': '63', 'year': '2007', 'journal-title': 'Rev Pneumol Clin'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0095', 'article-title': 'Hydroxychloroquine application is associated with a decreased mortality ' 'in critically ill patients with COVID-19', 'author': 'Yu', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0100', 'article-title': 'No evidence of clinical efficacy of hydroxychloroquine in patients ' 'hospitalized for COVID-19\xa0infection with oxygen requirement: results ' 'of a study using routinely collected data to emulate a target trial', 'author': 'Mahevas', 'year': '2020', 'journal-title': 'MedRxiv'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0105', 'doi-asserted-by': 'crossref', 'DOI': '10.1056/NEJMoa2012410', 'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with ' 'COVID-19', 'author': 'Geleris', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.phclin.2020.06.001_bib0110', 'first-page': '31180', 'article-title': 'Hydroxychloroquine or chloroquine with or without macrolide for ' 'treatment of COVID-19: a multinational registry analysis', 'volume': '20', 'author': 'Mehra', 'year': '2020', 'journal-title': 'Lancet'}], 'container-title': 'Le Pharmacien Hospitalier et Clinicien', 'original-title': [], 'language': 'fr', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2211104220300771?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2211104220300771?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 11, 22]], 'date-time': '2020-11-22T12:03:06Z', 'timestamp': 1606046586000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2211104220300771'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 12]]}, 'references-count': 11, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 12]]}}, 'alternative-id': ['S2211104220300771'], 'URL': 'http://dx.doi.org/10.1016/j.phclin.2020.06.001', 'relation': {}, 'ISSN': ['2211-1042'], 'subject': [], 'container-title-short': 'Le Pharmacien Hospitalier et Clinicien', 'published': {'date-parts': [[2020, 12]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Effet bénéfique de l’association hydroxychloroquine/azithromycine dans le ' 'traitement des patients âgés atteints de la COVID-19\xa0: résultats d’une étude ' 'observationnelle', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Le Pharmacien Hospitalier et Clinicien', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.phclin.2020.06.001', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Masson SAS. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}]}